Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Prednisolone | Case report

Avacopan/methylprednisolone/prednisolone

Diabetes mellitus and vanishing bile duct syndrome

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Yamaguchi S, et al. A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan. Rheumatology 63: E120-E122, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1093/rheumatology/kead285 Yamaguchi S, et al. A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan. Rheumatology 63: E120-E122, No. 4, Apr 2024. Available from: URL: https://​dx.​doi.​org/​10.​1093/​rheumatology/​kead285
Metadata
Title
Avacopan/methylprednisolone/prednisolone
Diabetes mellitus and vanishing bile duct syndrome
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57226-z

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Prednisolone

Case report

Etanercept

Case report

Pembrolizumab

Case report

Antineoplastics

Case report

Tacrolimus